MedPath

A study to fine efficacy of two Ayurvedic drugs in the treatment of pain and swelling of joints occurring after chikungunya fever.

Phase 3
Completed
Conditions
Health Condition 1: A920- Chikungunya virus disease
Registration Number
CTRI/2019/02/017659
Lead Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
32
Inclusion Criteria

1.Confirm case of Chikungunya fever with symptoms of pCHIK-CIR.

2.Patient willing to participate in the trial.

Exclusion Criteria

1.Age below 18 years & above 60 years.

2.Pregnant and lactating women

3. History of RA, Gout, Psoriatic arthritis, rheumatic fever, autoimmune disease, thyroid dysfunction, sarcoidosis, SLE before Chikungunya fever.

4.Patients suffering from: Malignant and accelerated hypertension, coronary artery disease, uncontrolled diabetes.

•Patient undergoing regular treatment for any other severe illness and also patients suffering from pulmonary tuberculosis, bone tuberculosis, carcinoma and HIV positive patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
efficacyTimepoint: 2 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
safetyTimepoint: 2 months
© Copyright 2025. All Rights Reserved by MedPath